Omic Approaches to Neurodevelopmental Disabilities

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

July 28, 2023

Study Completion Date

December 31, 2023

Conditions
Neurodevelopmental Disorders
Interventions
DIAGNOSTIC_TEST

WGS and transcriptome analysis

In light of the inconsistencies between the CNV and the phenotypic outcome, we expect that WGS analysis will reveal that part of these CNVs have a more complex structure than the one disentangled by CMA and FISH. We hypothesize that CNV should reflect a perturbed genome folding configuration at several hierarchical levels of chromatin organization, such as disruption of TADs boundaries. To investigate this aspect, we plan to examine expression profiles of immortalized lymphoblastoid B-cell lines (LBLs) derived from normal controls and patients. We expect to find a subset of down- or up-regulated genes located inside the rearranged region which in turn may alter the expression of other genes, possibly leading to perturbation of disease-related pathways

Trial Locations (1)

23842

Scientific Institute IRCCS Eugenio Medea, Bosisio Parini

All Listed Sponsors
lead

IRCCS Eugenio Medea

OTHER